CA 2024 * | 48,96 Md 45,44 Md 44,4 Md | CA 2025 * | 50,79 Md 47,14 Md 46,06 Md | Capitalisation | 203 Md 189 Md 184 Md |
---|---|---|---|---|---|
Résultat net 2024 * | 10,5 Md 9,75 Md 9,52 Md | Résultat net 2025 * | 12,07 Md 11,2 Md 10,95 Md | VE / CA 2024 * | 4,42 x |
Dette nette 2024 * | 12,88 Md 11,95 Md 11,68 Md | Dette nette 2025 * | 11,28 Md 10,47 Md 10,23 Md | VE / CA 2025 * | 4,23 x |
PER 2024 * |
19,7
x | PER 2025 * |
16,9
x | Employés | 76 057 |
Rendement 2024 * |
3,62% | Rendement 2025 * |
3,76% | Flottant | 85,22% |
Dernier transcript sur Novartis AG
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Chief Executive Officer | 48 | 01/01/05 | |
Director of Finance/CFO | 59 | 01/01/03 | |
Shreeram Aradhye
CTO | Chief Tech/Sci/R&D Officer | 62 | 16/05/22 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Bill Winters
BRD | Director/Board Member | 62 | 01/01/13 |
Simon Moroney
BRD | Director/Board Member | 65 | 28/02/20 |
Chairman | 68 | 01/01/13 |
Nom | PEA | Position | Varia. 1 janv. | Notation |
---|---|---|---|---|
ARCHEA FUND PATRIMOINE B1 | Non | 15.91M EUR | +22,00% | |
BÉTELGEUSE | Non | 1.02M EUR | +18,00% | |
BELLATRIX C | Non | 2.41M EUR | +7,00% | |
AXAWF SWITZERLAND EQ A CAP CHF | Non | 16.86M CHF | +7,00% | |
AI NATURAL CPTL TRSTN GLB EQ I USD ACC | Non | 1.05M USD | +13,00% |
Varia. 1 janv. | Capi. | |
---|---|---|
+32,36% | 695 Md | |
+26,51% | 568 Md | |
-4,40% | 361 Md | |
+19,46% | 330 Md | |
+3,50% | 283 Md | |
+16,34% | 239 Md | |
-9,08% | 198 Md | |
+8,62% | 168 Md | |
+4,78% | 125 Md |